Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc
Journal website https://jem.elmerpub.com

Original Article

Volume 16, Number 2, April 2026, pages 70-81


From Inflammation to Endocrine Dysregulation: Thyroid Hormonal Alterations in COVID-19

Figures

↓  Figure 1. Thyroid status in patients with active COVID-19 infection (group 1). COVID-19: coronavirus disease 2019.
Figure 1.
↓  Figure 2. Functional thyroid status in post-COVID patients (group 2). COVID: coronavirus disease.
Figure 2.
↓  Figure 3. Thyroid diagnosis in post-COVID patients (group 2). COVID: coronavirus disease.
Figure 3.
↓  Figure 4. ROC curve analysis for determining the optimal cut-off value of HIF-1α in COVID-19 disease. COVID-19: coronavirus disease 2019; HIF-1α: hypoxia-inducible factor-1 alpha; ROC: receiver operating characteristic.
Figure 4.

Tables

↓  Table 1. Demographic Characteristics of the Participants by Group
 
VariableGroup 1 (n = 33)Group 2 (n = 35)Group 3 (n = 33)
SD: standard deviation.
Age (mean ± SD)69.88 ± 11.8945.24 ± 14.4746.73 ± 13.01
Gender
  Male (n, %)15 (45.5%)11 (31.4%)3 (9.1%)
  Female (n, %)18 (54.5%)24 (68.6%)30 (90.9%)

 

↓  Table 2. Thyroid Parameters in the Three Study Groups
 
ParametersGroup 1 (n = 33)Group 2 (n = 35)Group 3 (n = 33)P-value (1–2/2–3/1–3)
Values are expressed as mean ± SD and Me (IQR). Overall between-group differences were assessed using the Kruskal–Wallis test, and when appropriate, pairwise comparisons between groups were performed using the Mann–Whitney U test. A P-value < 0.05 was considered statistically significant. FT3: free triiodothyronine; FT4: free thyroxine; Tg: thyroglobulin; TPO: thyroid peroxidase; TSH: thyroid-stimulating hormone.
TSH (mIU/L)1.35 ± 1.21
1.30 (1.32)
2.57 ± 2.95
1.78 (1.76)
4.51 ± 1.23
2.29 (3.23)
0.063/0.240/0.000
FT3 (pmol/L)3.03 ± 0.94
2.81 (1.28)
6.52 ± 8.34
4.48 (1.33)
5.09 ± 0.87
4.98 (1.58)
0.000/0.077/0.000
FT4 (pmol/L)21.17 ± 28.25
13.96 (2.90)
30.58 ± 40.73
14.04 (2.16)
21.50 ± 19.23
13.56 (1.91)
0.091
Tg (ng/mL)17.66 ± 4.13
11.90 (10.57)
16.86 ± 6.02
12.38 (39.51)
17.24 ± 3.01
15.23 (19.47)
0.404
TPO (pg/mL)137.39 ± 211.07
47.80 (113.60)
53.71 ± 134.15
16.87 (55.66)
186.94 ± 146.21
129.33 (195.00)
0.089

 

↓  Table 3. Selected Cytokines Associated With Immune Response Differences Between Groups
 
MarkerGroup 1 (n = 33)Group 2 (n = 35)Group 3 (n = 33)P-value (1–2/2–3/1–3)
Values are expressed as mean ± SD and Me (IQR). Pairwise comparisons between groups were performed using the Mann–Whitney U test. A P-value < 0.05 was considered statistically significant. IFN-γ: interferon-gamma; IL-7: interleukin-7; IL-10: interleukin-10; IL-17A: interleukin-17A.
IL-17A (pg/mL)29.45 ± 4.90
28.07 (3.86)
32.48 ± 27.84
25.13 (5.35)
41.91 ± 37.26
29.04 (7.71)
0.001/0.000/0.142
IL-10 (pg/mL)4.54 ± 4.75
2.92 (2.10)
2.77 ± 2.89
1.86 (0.96)
3.10 ± 1.31
3.02 (0.83)
0.005/0.001/0.402
IL-7 (pg/mL)36.70 ± 10.8
36.76 (13.25)
27.27 ± 8.35
26.73 (13.25)
58.06 ± 30.14
51.41 (26.13)
0.000/0.000/0.000
IFN-γ (pg/mL)12.23 ± 3.33
11.17 (5.48)
8.64 ± 4.94
8.75 (7.83)
15.01 ± 6.17
13.12 (9.10)
0.003/0.000/0.106

 

↓  Table 4. Markers of Oxidative and Hypoxic Stress in the Three Study Groups
 
МаrkersGroup 1 (n = 33)Group 2 (n = 35)Group 3 (n = 33)P-value (1–2/2–3/1–3)
Values are expressed as mean ± SD and Me (IQR). Pairwise comparisons between groups were performed using the Mann–Whitney U test. A P-value < 0.05 was considered statistically significant. HIF-1α: hypoxia-inducible factor-1 alpha; NFE2L2: nuclear factor erythroid 2-related factor 2.
HIF-1α (pg/mL)1321.51 ± 1224.92
1035.67 (878.89)
424.33 ± 321.3
364.67 (357.71)
558.87 ± 458.98
373.96 (412.77)
0.000/0.134/0.000
NFE2L2 (pg/mL)229.23 ± 69.04
226.90 (92.53)
185.97 ± 146.56
148.98 (120.64)
220.58 ± 107.32
214.31 (180.53)
0.004/0.069/0.595

 

↓  Table 5. ROC Analysis of HIF-1α to Distinguish Patients With Active COVID-19 Infection From Healthy Individuals
 
VariableAUC (95% CI)P-valueCut-off (pg/mL)Sensitivity (%)Specificity (%)
AUC: area under the curve; CI: confidence interval; COVID-19: coronavirus disease 2019; HIF-1α: hypoxia-inducible factor-1 alpha; ROC: receiver operating characteristic.
HIF-1α0.771 (0.644–0.897)< 0.001842.60.670.83

 

↓  Table 6. Correlations Between Immunological and Thyroid Parameters in the Studied Groups
 
CorrelationsGroup 1Group 2Group 3
Data are presented as Spearman correlation coefficients (r). Statistical significance was considered at P < 0.05. FT3: free triiodothyronine; FT4: free thyroxine; IL-7: interleukin-7; IL-10: interleukin-10; TPO: thyroid peroxidase.
IL-7–TPOr = 0.390, P = 0.049--
IL-7–FT3r = −0.440, P = 0.021--
FT4–IL-10-r = 0.438, P = 0.014r = −0.418, P = 0.042
FT3–IL-10--r = −0.631, P = 0.001